Completed PHASE4 INTERVENTIONAL 3-arm NCT03930433

The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm

Sponsor: Korea University Anam Hospital

Interventions Diltiazem Nebivolol Nebivolol+Diltiazem

Updated 7 times since 2019 Last updated: Mar 8, 2020 Started: Jan 1, 2018 Primary completion: Mar 31, 2019 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Vasospasm, this trial is completed. The trial is conducted by Korea University Anam Hospital and has accumulated 7 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Apr 2020 — Jan 2021 [monthly]

Completed PHASE4
May 2019 — Apr 2020 [monthly]

Completed PHASE4

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea University Anam Hospital
Korea University Ansan Hospital
Korea University Guro Hospital
Severance Hospital

Data source: Korea University Anam Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea